Leibniz Institute on Aging - Fritz Lipmann Institute, Jena, Germany.
Elife. 2024 Sep 4;13:RP93256. doi: 10.7554/eLife.93256.
Proteasomes are essential molecular machines responsible for the degradation of proteins in eukaryotic cells. Altered proteasome activity has been linked to neurodegeneration, auto-immune disorders and cancer. Despite the relevance for human disease and drug development, no method currently exists to monitor proteasome composition and interactions in vivo in animal models. To fill this gap, we developed a strategy based on tagging of proteasomes with promiscuous biotin ligases and generated a new mouse model enabling the quantification of proteasome interactions by mass spectrometry. We show that biotin ligases can be incorporated in fully assembled proteasomes without negative impact on their activity. We demonstrate the utility of our method by identifying novel proteasome-interacting proteins, charting interactomes across mouse organs, and showing that proximity-labeling enables the identification of both endogenous and small-molecule-induced proteasome substrates.
蛋白酶体是真核细胞中负责蛋白质降解的重要分子机器。蛋白酶体活性的改变与神经退行性疾病、自身免疫性疾病和癌症有关。尽管与人类疾病和药物开发密切相关,但目前尚无方法在动物模型中监测体内蛋白酶体的组成和相互作用。为了填补这一空白,我们开发了一种基于蛋白酶体与广谱生物素连接酶标记的策略,并生成了一种新的小鼠模型,通过质谱法定量分析蛋白酶体相互作用。我们表明,生物素连接酶可以在不影响其活性的情况下掺入完全组装的蛋白酶体中。我们通过鉴定新的蛋白酶体相互作用蛋白、绘制跨小鼠器官的相互作用组以及表明邻近标记能够鉴定内源性和小分子诱导的蛋白酶体底物,证明了我们方法的实用性。